US Stock MarketDetailed Quotes

Pyxis Oncology (PYXS)

Watchlist
  • 2.280
  • +0.070+3.17%
Close May 15 15:59 ET
  • 2.260
  • -0.020-0.88%
Post 19:13 ET
144.45MMarket Cap-1.75P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Pyxis Oncology (PYXS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
-14.17%13.86M
11.04M
0
2.82M
0
16.15M
0
0
0
Operating revenue
--0
-14.17%13.86M
--11.04M
--0
--2.82M
--0
--16.15M
--0
--0
--0
Cost of revenue
402.74%2.39M
2.39M
0
0
0
475K
0
0
0
Gross profit
-26.81%11.47M
8.65M
0
2.82M
0
15.67M
0
0
0
Operating expense
6.31%24.36M
13.93%95.89M
41.04%26.95M
-1.23%23.46M
12.67%22.57M
7.70%22.91M
2.40%84.17M
7.53%19.11M
-6.31%23.75M
10.55%20.03M
Selling and administrative expenses
-25.43%4.38M
-12.69%22.19M
3.01%5.23M
-5.99%5.65M
-10.56%5.44M
-28.82%5.87M
-22.05%25.42M
-17.52%5.08M
-43.63%6.01M
-9.67%6.08M
-General and administrative expense
-25.43%4.38M
-12.69%22.19M
3.01%5.23M
-5.99%5.65M
-10.56%5.44M
-28.82%5.87M
-22.05%25.42M
-17.52%5.08M
-43.63%6.01M
-9.67%6.08M
Research and development costs
17.24%19.98M
25.45%73.7M
54.81%21.71M
0.38%17.81M
22.79%17.13M
30.82%17.04M
18.47%58.75M
20.82%14.02M
20.79%17.74M
22.49%13.95M
Operating profit
-6.31%-24.36M
-23.25%-84.42M
4.24%-18.3M
1.23%-23.46M
1.41%-19.75M
-308.81%-22.91M
16.67%-68.5M
-7.53%-19.11M
6.31%-23.75M
-10.55%-20.03M
Net non-operating interest income expense
-63.17%457K
-48.71%3.61M
-62.96%600K
-58.07%774K
-50.82%995K
-19.94%1.24M
6.17%7.04M
1.63%1.62M
8.14%1.85M
22.16%2.02M
Non-operating interest income
-63.17%457K
-48.71%3.61M
-62.96%600K
-58.07%774K
-50.82%995K
-19.94%1.24M
6.17%7.04M
1.63%1.62M
8.14%1.85M
22.16%2.02M
Other net income (expense)
22.52%631K
114.28%2.58M
103.42%692K
-2.98%684K
-3.39%684K
-35.54%515K
-1,115.65%-18.04M
-3,615.63%-20.25M
17.89%705K
25.53%708K
Special income (charges)
----
--0
----
----
----
----
---20.96M
----
----
----
-Less:Impairment of capital assets
----
--0
----
----
----
----
--20.96M
----
----
----
Other non- operating income (expenses)
22.52%631K
-12.00%2.58M
-3.08%692K
-2.98%684K
-3.39%684K
-35.54%515K
64.75%2.93M
23.96%714K
17.89%705K
25.53%708K
Income before tax
-9.99%-23.27M
1.59%-78.24M
54.94%-17M
-3.77%-22M
-4.45%-18.07M
-549.82%-21.16M
-7.73%-79.5M
-141.94%-37.74M
8.01%-21.2M
-8.80%-17.3M
Income tax
164.05%1.39M
150.97%1.1M
0
283K
-2.16M
-2.16M
0
0
Net income
-9.99%-23.27M
-2.96%-79.62M
49.10%-18.11M
-3.77%-22M
-6.09%-18.35M
-549.82%-21.16M
-4.80%-77.33M
-128.06%-35.57M
8.01%-21.2M
-8.80%-17.3M
Net income continuous Operations
-9.99%-23.27M
-2.96%-79.62M
49.10%-18.11M
-3.77%-22M
-6.09%-18.35M
-549.82%-21.16M
-4.80%-77.33M
-128.06%-35.57M
8.01%-21.2M
-8.80%-17.3M
Minority interest income
Net income attributable to the parent company
-9.99%-23.27M
-2.96%-79.62M
49.10%-18.11M
-3.77%-22M
-6.09%-18.35M
-549.82%-21.16M
-4.80%-77.33M
-128.06%-35.57M
8.01%-21.2M
-8.80%-17.3M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-9.99%-23.27M
-2.96%-79.62M
49.10%-18.11M
-3.77%-22M
-6.09%-18.35M
-549.82%-21.16M
-4.80%-77.33M
-128.06%-35.57M
8.01%-21.2M
-8.80%-17.3M
Basic earnings per share
-5.71%-0.37
3.03%-1.28
50.85%-0.29
0.00%-0.35
-3.45%-0.3
-483.33%-0.35
28.65%-1.32
-78.79%-0.59
37.50%-0.35
29.27%-0.29
Diluted earnings per share
-5.71%-0.37
3.03%-1.28
50.85%-0.29
0.00%-0.35
-3.45%-0.3
-483.33%-0.35
28.65%-1.32
-78.79%-0.59
37.50%-0.35
29.27%-0.29
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0-14.17%13.86M11.04M02.82M016.15M000
Operating revenue --0-14.17%13.86M--11.04M--0--2.82M--0--16.15M--0--0--0
Cost of revenue 402.74%2.39M2.39M000475K000
Gross profit -26.81%11.47M8.65M02.82M015.67M000
Operating expense 6.31%24.36M13.93%95.89M41.04%26.95M-1.23%23.46M12.67%22.57M7.70%22.91M2.40%84.17M7.53%19.11M-6.31%23.75M10.55%20.03M
Selling and administrative expenses -25.43%4.38M-12.69%22.19M3.01%5.23M-5.99%5.65M-10.56%5.44M-28.82%5.87M-22.05%25.42M-17.52%5.08M-43.63%6.01M-9.67%6.08M
-General and administrative expense -25.43%4.38M-12.69%22.19M3.01%5.23M-5.99%5.65M-10.56%5.44M-28.82%5.87M-22.05%25.42M-17.52%5.08M-43.63%6.01M-9.67%6.08M
Research and development costs 17.24%19.98M25.45%73.7M54.81%21.71M0.38%17.81M22.79%17.13M30.82%17.04M18.47%58.75M20.82%14.02M20.79%17.74M22.49%13.95M
Operating profit -6.31%-24.36M-23.25%-84.42M4.24%-18.3M1.23%-23.46M1.41%-19.75M-308.81%-22.91M16.67%-68.5M-7.53%-19.11M6.31%-23.75M-10.55%-20.03M
Net non-operating interest income expense -63.17%457K-48.71%3.61M-62.96%600K-58.07%774K-50.82%995K-19.94%1.24M6.17%7.04M1.63%1.62M8.14%1.85M22.16%2.02M
Non-operating interest income -63.17%457K-48.71%3.61M-62.96%600K-58.07%774K-50.82%995K-19.94%1.24M6.17%7.04M1.63%1.62M8.14%1.85M22.16%2.02M
Other net income (expense) 22.52%631K114.28%2.58M103.42%692K-2.98%684K-3.39%684K-35.54%515K-1,115.65%-18.04M-3,615.63%-20.25M17.89%705K25.53%708K
Special income (charges) ------0-------------------20.96M------------
-Less:Impairment of capital assets ------0------------------20.96M------------
Other non- operating income (expenses) 22.52%631K-12.00%2.58M-3.08%692K-2.98%684K-3.39%684K-35.54%515K64.75%2.93M23.96%714K17.89%705K25.53%708K
Income before tax -9.99%-23.27M1.59%-78.24M54.94%-17M-3.77%-22M-4.45%-18.07M-549.82%-21.16M-7.73%-79.5M-141.94%-37.74M8.01%-21.2M-8.80%-17.3M
Income tax 164.05%1.39M150.97%1.1M0283K-2.16M-2.16M00
Net income -9.99%-23.27M-2.96%-79.62M49.10%-18.11M-3.77%-22M-6.09%-18.35M-549.82%-21.16M-4.80%-77.33M-128.06%-35.57M8.01%-21.2M-8.80%-17.3M
Net income continuous Operations -9.99%-23.27M-2.96%-79.62M49.10%-18.11M-3.77%-22M-6.09%-18.35M-549.82%-21.16M-4.80%-77.33M-128.06%-35.57M8.01%-21.2M-8.80%-17.3M
Minority interest income
Net income attributable to the parent company -9.99%-23.27M-2.96%-79.62M49.10%-18.11M-3.77%-22M-6.09%-18.35M-549.82%-21.16M-4.80%-77.33M-128.06%-35.57M8.01%-21.2M-8.80%-17.3M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -9.99%-23.27M-2.96%-79.62M49.10%-18.11M-3.77%-22M-6.09%-18.35M-549.82%-21.16M-4.80%-77.33M-128.06%-35.57M8.01%-21.2M-8.80%-17.3M
Basic earnings per share -5.71%-0.373.03%-1.2850.85%-0.290.00%-0.35-3.45%-0.3-483.33%-0.3528.65%-1.32-78.79%-0.5937.50%-0.3529.27%-0.29
Diluted earnings per share -5.71%-0.373.03%-1.2850.85%-0.290.00%-0.35-3.45%-0.3-483.33%-0.3528.65%-1.32-78.79%-0.5937.50%-0.3529.27%-0.29
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -